Immunis Chairman Dr. Hans Keirstead to Present at Advanced Therapies in Portugal

IRVINE, Calif.–(BUSINESS WIRE)– #ClinicalTrials–Immunis, Inc., a private biotech company developing novel cellular secretome therapies for age and disease-related immune decline, is delighted that its Chairman, Dr. Hans Keirstead, will present at the Advanced Therapies Conference in Portugal. The Advanced Therapies Conference is a premier gathering of thought leaders and pioneers…
Click here to view original post